Kura Oncology, Inc. (KURA)
13.25
+0.10
(+0.76%)
USD |
NASDAQ |
Sep 04, 16:00
13.26
+0.01
(+0.08%)
Pre-Market: 20:00
Kura Oncology SG&A Expense (TTM) : 135.28M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 135.28M |
| March 31, 2026 | 128.70M |
| December 31, 2025 | 119.98M |
| September 30, 2025 | 104.91M |
| June 30, 2025 | 90.25M |
| March 31, 2025 | 81.76M |
| December 31, 2024 | 77.11M |
| September 30, 2024 | 67.27M |
| June 30, 2024 | 62.24M |
| March 31, 2024 | 57.38M |
| December 31, 2023 | 50.57M |
| September 30, 2023 | 48.83M |
| June 30, 2023 | 47.30M |
| March 31, 2023 | 46.56M |
| December 31, 2022 | 47.05M |
| September 30, 2022 | 46.65M |
| June 30, 2022 | 46.34M |
| March 31, 2022 | 47.83M |
| December 31, 2021 | 46.54M |
| September 30, 2021 | 43.26M |
| June 30, 2021 | 39.55M |
| March 31, 2021 | 34.45M |
| December 31, 2020 | 31.50M |
| Date | Value |
|---|---|
| September 30, 2020 | 28.19M |
| June 30, 2020 | 25.73M |
| March 31, 2020 | 22.71M |
| December 31, 2019 | 19.65M |
| September 30, 2019 | 18.70M |
| June 30, 2019 | 17.89M |
| March 31, 2019 | 17.24M |
| December 31, 2018 | 16.10M |
| September 30, 2018 | 14.42M |
| June 30, 2018 | 12.46M |
| March 31, 2018 | 10.94M |
| December 31, 2017 | 9.651M |
| September 30, 2017 | 8.75M |
| June 30, 2017 | 8.135M |
| March 31, 2017 | 7.712M |
| December 31, 2016 | 7.963M |
| September 30, 2016 | 7.717M |
| June 30, 2016 | 7.768M |
| March 31, 2016 | 7.419M |
| December 31, 2015 | 6.088M |
| September 30, 2015 | 4.359M |
| June 30, 2015 | 2.566M |
| March 31, 2015 | 1.06M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 30.77M |
| Fortress Biotech, Inc. | 68.84M |
| Syndax Pharmaceuticals, Inc. | 173.97M |
| Spero Therapeutics, Inc. | 19.85M |
| Gossamer Bio, Inc. | 47.94M |